Company intelligence / Profile preview

Univalor

Montreal, Quebec, Canada

Ownership: Private
Development stage: Other

Overview

Univalor is a university technology transfer organization that commercializes scientific discoveries and technological innovations from Université de Montréal and its affiliated health centers, Polytechnique Montréal, and HEC Montréal. It does not develop drugs itself but supports the maturation and commercialization of academic research, particularly in life sciences and health, leading to licensing deals, spin-off companies, and partnerships with biotech and pharma firms[3][6][7].

Therapeutic areas: EndocrinologyCardiovascular
Modalities: Small moleculeMedical algorithmDrug delivery platform
Industry: Drug Discovery Services

Partnerships

AmorChem (venture capital fund for early-stage life science projects)Sanderling Ventures (venture capital for biotech spin-offs)Logibec (healthcare IT licensee)

Beyond the preview

Go deeper on Univalor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Univalor.

Explore the full profile